Brought to you by 
AMD device firm Oraya gets $42mm in Series C round
22 Jul 2009
Executive Summary
Oraya Therapeutics (devices for neovascular ophthalmic diseases) grossed $42mm through its Series C financing, which was led by first-time investors Scale Venture Partners and Domain Associates and included existing backers Essex Woodlands Health Ventures and Synergy Life Partners. Members of Scale and Domain joined the company's board.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AMD device firm Oraya gets $42mm in Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice